Purpose: We sought to describe sarcoidosis mortality in the United States from 1979 through 1991.
Methods: We analyzed death certificate reports compiled by the National Center for Health Statistics for the period 1979 through 1991.
Results: Of the 26,866,600 people who died during the study period, 9,014 had a diagnosis of sarcoidosis listed on their death certificates. We restricted our study group to 5,791 people who died because of sarcoidosis or one of its complications. Among men, age-adjusted mortality rates increased from 1.3 per 1,000,000 in 1979 to 1.6 per 1,000,000 in 1991, and among women, these rates increased from 1.9 per 1,000,000 in 1979 to 2.5 per 1,000,000 in 1991. Age-adjusted mortality rates were consistently higher among blacks than whites. Age-adjusted mortality rates stratified by race, varied by state. Among whites, the highest rates were in northern states, while among blacks, the highest rates were in the Middle Atlantic and northern Midwestern states.
Conclusions: Reported mortality due to sarcoidosis varies by region, sex, and race. We cannot determine whether these differences are related to characteristics of the disease, or problems in death certification and coding.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/S0002-9343(97)89518-6 | DOI Listing |
Front Public Health
March 2025
Center for Indigenous Health, Johns Hopkins University, Baltimore, MD, United States.
Background: According to the National Center for Health Data, in 2017 American Indians in North Dakota experience the highest age-adjusted mortality rate in the United States. Data shows that the age-adjusted death rate for all North Dakotans has steadily declined since 1979. However, mortality remains high among American Indians in North Dakota.
View Article and Find Full Text PDFJ Natl Compr Canc Netw
March 2025
5Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA.
Background: Rural areas have higher cardiovascular disease (CVD) incidence and age-adjusted mortality rates in the general population. However, the impact of rurality on CVD development and outcomes in patients with prostate cancer (PC) remains unclear.
Patients And Methods: This retrospective cohort study used the SEER-Medicare database to analyze males aged ≥65 years diagnosed with PC between 2009 and 2017.
J Investig Med
March 2025
Department of Internal Medicine/Rheumatology, New York Medical College at Saint Michael's Medical Center, Newark, USA.
Systemic lupus erythematosus (SLE) is linked with an increased risk of cancers, particularly hematologic malignancies. Cancer mortality among patients with SLE in the United States (U.S.
View Article and Find Full Text PDFBMC Public Health
March 2025
Departamento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo-SP, Brazil.
Background: Several nonpharmaceutical interventions, such as masking, were mandated or recommended during the Coronavirus disease 2019 (COVID-19) pandemic. This study's primary objective is to investigate the relationship between population-level mask usage and excess mortality across Europe.
Methods: We collected data on mask usage and other relevant variables from 24 European countries during 2020-2021, a period in which mask policies varied widely across nations, providing an ideal basis for a natural experiment.
Cancer Rep (Hoboken)
March 2025
Department of Surgery, Urology, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Background: Prostate cancer (PCa) is a significant contributor to male mortality globally, including in the Democratic Republic of the Congo (DRC). Various factors play a role in its onset and progression. The impact of trace elements and other risk factors on the survival of PCa patients is not extensively studied in this setting.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!